OSR Health
OSRH
OSRH was delisted on the 25th of August, 2026.
1 hedge funds and large institutions have $2K invested in OSR Health in 2026 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.
2.6% less ownership
Funds ownership: 2.6% → 0% (-2.6%)
93% less funds holding
Funds holding: 14 → 1 (-13)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $208K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
-$46.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$40.4K |
| 3 |
Jane Street
New York
|
-$40.2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$31.8K |
| 5 |
Two Sigma Securities
New York
|
-$14.7K |
OSRH Hedge Fund Activity: Q3 2026 in Review
1 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in OSR Health (OSRH) for Q3 2026, worth a combined $2K — down 99% from $211K a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of OSRH and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Fiduciary Trust, exiting entirely with an estimated $46.9K sold.
- 1 institutional investor held OSR Health (OSRH) as of Q3 2026, down from 14 in Q2 2026.
- Funds reported $2K of OSR Health stock for Q3 2026, down 99% quarter-over-quarter.
- 0 funds opened new OSR Health positions in Q3 2026 and 12 closed out, a net change of -12 holders.
- The largest OSR Health seller in Q3 2026 was Vanguard Fiduciary Trust, an estimated $46.9K sold.
Based on aggregated 13F filings for Q3 2026.